Estraderm Articles
KV to use Acrux' spray for six new products
1 September 2008
Stock Commentary - New York week to July 23, 2007
30 July 2007
Final appro for Mylan's Estradiol strengths
26 July 2006
Schering AG's osteoperosis patch gets US go ahead
9 January 2006
BioSante's Bio-E-Gel completes Phase III
18 April 2005
Schering AG's Menostar approved in the USA
14 June 2004
Schering AG's Climara Pro launched in USA
16 February 2004
Schering AG raises earnings expectations
27 July 2001
Schering AG 1st-qtr net income rises 19%
25 April 2001
Schering AG to focus on special markets
20 April 2001
Low-dose Climara cleared in USA
11 April 2001
1999 sales and profits up at Schering AG - updated story
10 February 2000
World's smallest HRT patch launched in USA
13 May 1999
Europe/US sales offset Asian crisis at Schering
9 February 1999
US FDA Approves Groupe Fournier's Esclim
12 November 1998
Schering AG Profits Impacted By Asian Crisis
10 August 1998
Many US Companies Go Into The Black For 2nd Qtr
5 August 1998
Strong Start To 1998 By Schering AG
5 May 1998
Drug Delivery Sales "To Grow 15% A Year To 2005"
4 February 1998
Alora Launched In USA
30 May 1997
Ares-Serono Licenses Rights To Fournier HRT Products
7 April 1997
Novartis Pipeline: A Good Fit But Cuts Are Expected
18 March 1996
Novartis Pipeline: A Good Fit But Cuts Are Expected
18 March 1996
Fournier Will Remain Independent Company
23 October 1995
Flat Interim Results From Schering AG
14 August 1995
Ciba Reveals Pipeline With Broad Reach
17 April 1995
Metra Biosystems; Focus On Bone Disorders
20 February 1995
RHONE-POULENC: A TRANSFORMATION
16 August 1993
CIBA'S 1992 HEALTH CARE PROFITS SQUEEZED
5 April 1993
WORLD ENDOCRINE MARKET AND FORECASTS
29 March 1993
RHONE-POULENC RORER SALES $4 BILLION IN 1992
8 February 1993
HORMONE REPLACEMENT THERAPY: US REPORT
8 June 1992
Showing 1-42 of 42 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
